Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Current Hypertension Reports

Issue 4/2017

Content (12 Articles)

Gut Microbiome, Sympathetic Nervous System, and Hypertension (MK Raizada and EM Richards, Section Editors)

The Gut, Its Microbiome, and Hypertension

Elaine M. Richards, Carl J. Pepine, Mohan K. Raizada, Seungbum Kim

GUT MICROBIOME, SYMPATHETIC NERVOUS SYSTEM, AND HYPERTENSION (MK RAIZADA AND EM RICHARDS, SECTION EDITORS)

The Gut Microbiome, Energy Homeostasis, and Implications for Hypertension

Ruth A. Riedl, Samantha N. Atkinson, Colin M. L. Burnett, Justin L. Grobe, John R. Kirby

Gut Microbiome, Sympathetic Nervous System, and Hypertension (MK Raizada and EM Richards, Section Editors)

Microbial Short-Chain Fatty Acids and Blood Pressure Regulation

Jennifer L. Pluznick

Gut Microbiome, Sympathetic Nervous System, and Hypertension (MK Raizada and EM Richards, Section Editors)

Antihypertensive Effects of Probiotics

Iñaki Robles-Vera, Marta Toral, Miguel Romero, Rosario Jiménez, Manuel Sánchez, Francisco Pérez-Vizcaíno, Juan Duarte

Gut Microbiome, Sympathetic Nervous System, and Hypertension (MK Raizada and EM Richards, Section Editors)

Oral Microbiome and Nitric Oxide: the Missing Link in the Management of Blood Pressure

Nathan S. Bryan, Gena Tribble, Nikola Angelov

Gut Microbiome, Sympathetic Nervous System, and Hypertension (MK Raizada and EM Richards, Section Editors)

Gut Microbiome in Chronic Kidney Disease

R. G. Armani, A. Ramezani, A. Yasir, S. Sharama, M. E. F. Canziani, D. S. Raj

Gut Microbiome, Sympathetic Nervous System, and Hypertension (MK Raizada and EM Richards, Section Editors)

Gastrointestinal Tract: a Promising Target for the Management of Hypertension

Shiqiang Xiong, Qiang Li, Daoyan Liu, Zhiming Zhu

Gut Microbiome, Sympathetic Nervous System, and Hypertension (MK Raizada and EM Richards, Section Editors)

Obstructive Sleep Apnea-Induced Hypertension: Role of the Gut Microbiota

David J. Durgan

Resistant Hypertension (E Pimenta, Section Editor)

Preferred Fourth-Line Pharmacotherapy for Resistant Hypertension: Are We There Yet?

Hamish CG Prosser, Cynthia Gregory, Dagmara Hering, Graham S Hillis, Greg Perry, Johan Rosman, Carl Schultz, Mark Thomas, Gerald F Watts, Markus P Schlaich

Hypertension and Metabolic Syndrome (J Sperati, Section Editor)

Role of Orexin-A in Hypertension and Obesity

Roberta Imperatore, Letizia Palomba, Luigia Cristino

Hypertension and Metabolic Syndrome (J Sperati, Section Editor)

The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension

Zhe Huang, Aimin Xu, Bernard M. Y. Cheung

Secondary Hypertension: Nervous System Mechanisms (M Wyss, Section Editor)

DOCA-Salt Hypertension: an Update

Tyler Basting, Eric Lazartigues

Mar 17
Issue: 3/2017
May 17
Issue: 5/2017

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits